EASL Campus

A. You avoid anti-HCV therapy because he is actively injecting drugs

B. You perform a liver ultrasound to screen for hepatocellular carcinoma

C. You start therapy anyhow with Direct Acting Antivirals regardless of potential drug-drug interactions

D. If you treat, you don’t have to check for Sustained Virological Response (SVR) due to the nearly 100% rates of response

E. You wait to start anti-HCV treatment until he is stable under opioid substitution therapy